Nutritional Intervention Strategies for Cancer-Related Sarcopenia
DOI:
https://doi.org/10.54097/hsj5vr61Keywords:
Sarcopenia, Cancer, Nutritional Intervention, Protein Supplementation, Gut Microbiota.Abstract
Muscle loss in cancer patients, known clinically as cancer-related sarcopenia, represents a formidable challenge that directly undercuts treatment success and survival. This paper moves beyond a simple literature summary to offer a critical appraisal of nutritional tactics in this complex arena. People first map the landscape of the problem, detailing who is affected and the interplay of factors that drive muscle wasting, with a sharp focus on the damaging roles of persistent inflammation, scrambled protein metabolism, and a disrupted gut ecosystem. The core of the discussion then dissects modern nutritional strategies: the non-negotiable need for smart protein delivery, the nuanced evidence behind specific nutrients like omega-3s and vitamin D, and the intriguing promise of probiotics for gut health and muscle preservation. People argue for a paradigm shift toward earlier action, the extension of care into patients' homes, and the absolute necessity of combining dietary plans with physical therapy and medical treatment. Synthesizing current data, People conclude that the most powerful tool available is the dual application of high-quality protein and resistance exercise. True progress, however, demands care that is meticulously tailored to the individual and woven into every step of the cancer journey. The road ahead requires cracking the code of precision nutrition and building sustainable, long-term support systems to make these interventions genuinely effective.
Downloads
References
[1] Yu Baohai, Wu Wenjuan. Interpretation of the European Consensus on Sarcopenia. Journal of Hebei Medical University, 2019, 40(4): 373-379.
[2] Committee of Tumor Nutrition and Supportive Care of China Anti-Cancer Association. Clinical Diagnosis and Treatment Guidelines for Cancer-Related Sarcopenia. Electronic Journal of Metabolism and Nutrition of Cancer, 2022, 9(1): 24-34.
[3] Shi Xuexue, Zhang Qin, Yang Yunmei. Sarcopenia in Cancer Diagnosis, Treatment, and Prognosis. Chinese Journal of Practical Internal Medicine, 2022, 42(8): 643-646.
[4] Aleixo G, Willams GR, Nyrop KA, et al. Muscle composition and outcomes in patients with breast cancer: Meta-analysis and systematic review. Breast Cancer Res Treat, 2019, 177(3): 569-579.
[5] Wilkinson DJ, Piasecki M, Atherton PJ. The age-related loss of skeletal muscle mass and function: measurement and physiology of muscle fibre atrophy and muscle fibre loss in humans. Ageing Res Rev, 2018, 47: 123-132
[6] Uojima H, Chuma M, Tanaka Y, et al. Skeletal muscle mass influences tolerability and prognosis in hepatocellular carcinoma patients treated with lenvatinib. Liver Cancer, 2020, 9(2): 193-206
[7] Li Yi, Zhou Fuxiang. Impact of Sarcopenic Obesity on Clinical Outcomes in Cancer Patients. Electronic Journal of Tumor Metabolism and Nutrition, 2017, 4(4): 381-389.
[8] Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia. J Am Med Dir Assoc, 2014, 15(2): 95-101
[9] Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing, 2019, 48(1):16-31
[10] Coelho-Junior HJ, Milano-Teixeira L, Rodrigues B,etal. Relative protein intake and physical function in older adults: a Systematic review and meta-analysis of observational studies. Nutrients, 2018, 10(9): 1330.
[11] Hagve M, Pereira SL, Walker DK, et al. Statin treatment reduces leucine turnover, but does not affec tendogenous production of beta-hydroxy- beta- methylbutyrate (HMB). Metabolism, 2024, 156: 155920.
[12] Hua Chao, Chen Geliang, Wen Xiaoli, et al. Effect of HMB on Muscle in Malnourished Elderly Community-Dwelling Adults. Electronic Journal of Tumor Metabolism and Nutrition, 2017, 4(1): 72-77.
[13] Zhang Y, Zhang J, Zhu L, et al. A narrative review of nutritional therapy for gastrointestinal cancer patients underwent surgery. J Invest Surg, 2023, 36(1):2150337.
[14] Tessjer AJ, Chevalier S. An update on protein, leucine, omega-3 fatty acids, and Vitamin D in the prevention and treatment of sarcopenia and functional decline. Nutrients, 2018, 10(8): 1099
[15] Grosicki GJ, Fielding RA, Lustgarten MS. Gut microbiota contribute to age-related changes in skeletal muscle size, composition, and function: biological basis for a gut-muscle axis. Calcif Tissue Int, 2018, 102(4): 433- 442.
[16] Sovran B, Hugenholtz F, Elderman M, et al. Age-associated impairment of the mucus barrier function is associated with profound changes in microbiota and immunity. Sci Rep, 2019, 9(1): 1437.
[17] Kang L, Li P, Wang D, et al. Alterations in intestinal microbiota diversity, composition, and function in patients with sarcopenia. Sci Rep, 2021, 11(1):4628
[18] Lee MC, Tu YT, Lee CC, et al. Lactobacillus plantarum TWK10 improves muscle mass and functional performance in frail older adults: a randomized, double-blind clinical trial. Micro organisms, 2021, 9(7): 1466.
[19] Prokopidis K, Giannos P, Kirwan R, et al. Impact of probiotics on muscle mass, muscle strength and lean mass: a systematic review and meta-analysis of randomized controlled trials. J Cachexia Sarcopenia Muscle, 2023, 14(1): 30-44.
[20] Lyell NJ, Kitano M, Smith B, et al. The effect of preoperative nutritional status on postoperative complications and overall survival in patients undergoing pelvic exenteration: a multi-disciplinary, multi-institutional cohort study. Am J Surg, 2019, 218 (2) : 275-280.
[21] Morton M, Patterson J, Sciuva J, et al. Malnutrition, sarcopenia, and cancer cachexia in gynecologic cancer. Gynecol Oncol, 2023, 175: 142-155.
[22] Allanson ER, Peng Y, Choi A, et al. A systematic review and meta-analysis of sarcopenia as a prognostic factor in gynecological malignancy. Int J Gynecol Cancer, 2020, 30(11): 1791-1797.
[23] Matulewicz RS, Brennan J, Pruthi RS, et al. Radical cystectomy perioperative care redesign. Urology, 2015, 86(6): 1076-1086.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

